Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 32.67
(0.28%)
CNY 32.67
(0.28%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.57 Billion CNY | -6.24% |
| 2022 | 2.75 Billion CNY | 13.15% |
| 2021 | 2.43 Billion CNY | 283.57% |
| 2020 | 633.91 Million CNY | 201.23% |
| 2019 | 210.44 Million CNY | 36.09% |
| 2018 | 154.63 Million CNY | 21.27% |
| 2017 | 127.51 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 2.52 Billion CNY | 0.43% |
| 2024 Q1 | 2.57 Billion CNY | -0.21% |
| 2024 Q2 | 2.51 Billion CNY | -2.15% |
| 2023 Q4 | 2.57 Billion CNY | 0.99% |
| 2023 FY | 2.57 Billion CNY | -6.24% |
| 2023 Q3 | 2.55 Billion CNY | 1.04% |
| 2023 Q2 | 2.52 Billion CNY | -7.38% |
| 2023 Q1 | 2.72 Billion CNY | -0.8% |
| 2022 Q3 | 2.98 Billion CNY | 0.39% |
| 2022 Q2 | 2.97 Billion CNY | -6.51% |
| 2022 Q1 | 3.18 Billion CNY | 30.86% |
| 2022 FY | 2.75 Billion CNY | 13.15% |
| 2022 Q4 | 2.75 Billion CNY | -7.88% |
| 2021 Q3 | 2.31 Billion CNY | 66.46% |
| 2021 FY | 2.43 Billion CNY | 283.57% |
| 2021 Q4 | 2.43 Billion CNY | 4.99% |
| 2021 Q1 | 976.21 Million CNY | 54.0% |
| 2021 Q2 | 1.39 Billion CNY | 42.52% |
| 2020 Q4 | 633.91 Million CNY | 0.0% |
| 2020 Q2 | 580.41 Million CNY | 0.0% |
| 2020 FY | 633.91 Million CNY | 201.23% |
| 2020 Q1 | 580.41 Million CNY | 0.0% |
| 2019 FY | 210.44 Million CNY | 36.09% |
| 2018 FY | 154.63 Million CNY | 21.27% |
| 2017 FY | 127.51 Million CNY | 0.0% |